Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mota

Showing results (441-450 of 454) with videos related to

Pageof 46
Sort By:
Plos One|November 20, 2009
Visualisation and quantitative analysis of the rodent malaria liver stage by real time imagingIvo H J Ploemen, Miguel Prudêncio, Bruno G Douradinha, et al.
Plos Pathogens|June 5, 2024
Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19Keyla S G de Sá, Luana A Amaral, Tamara S Rodrigues, et al.
Nature Medicine|December 24, 2013
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infectionPeter Liehl, Vanessa Zuzarte-Luís, Jennie Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Subcutaneous versus intravenous nivolumab for renal cell carcinomaL Albiges, M T Bourlon, M Chacón, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Nature Communications|January 9, 2021
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
Plos Pathogens|September 5, 2018
HLA-C downregulation by HIV-1 adapts to host HLA genotypeNathaniel D Bachtel, Gisele Umviligihozo, Suzanne Pickering, et al.
JCI Insight|January 5, 2021
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapyEva M Stevenson, Adam R Ward, Ronald Truong, et al.
NPJ Vaccines|August 30, 2018
A <i>Plasmodium berghei</i> sporozoite-based vaccination platform against human malariaAntónio M Mendes, Marta Machado, Nataniel Gonçalves-Rosa, et al.
Nature Communications|May 15, 2025
Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 studyDanielle K Sohai, Michael D Keller, Patrick J Hanley, et al.
Pageof 46

Showing results (441-450 of 454) with videos related to

Sort By:
Pageof 46
Plos One|November 20, 2009
Visualisation and quantitative analysis of the rodent malaria liver stage by real time imagingIvo H J Ploemen, Miguel Prudêncio, Bruno G Douradinha, et al.
Plos Pathogens|June 5, 2024
Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19Keyla S G de Sá, Luana A Amaral, Tamara S Rodrigues, et al.
Nature Medicine|December 24, 2013
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infectionPeter Liehl, Vanessa Zuzarte-Luís, Jennie Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Subcutaneous versus intravenous nivolumab for renal cell carcinomaL Albiges, M T Bourlon, M Chacón, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Nature Communications|January 9, 2021
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
Plos Pathogens|September 5, 2018
HLA-C downregulation by HIV-1 adapts to host HLA genotypeNathaniel D Bachtel, Gisele Umviligihozo, Suzanne Pickering, et al.
JCI Insight|January 5, 2021
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapyEva M Stevenson, Adam R Ward, Ronald Truong, et al.
NPJ Vaccines|August 30, 2018
A <i>Plasmodium berghei</i> sporozoite-based vaccination platform against human malariaAntónio M Mendes, Marta Machado, Nataniel Gonçalves-Rosa, et al.
Nature Communications|May 15, 2025
Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 studyDanielle K Sohai, Michael D Keller, Patrick J Hanley, et al.
Pageof 46